Nordio M - Search Results

1

The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.

Minozzi M, Nordio M, Pajalich R. Minozzi M, et al. Among authors: nordio m. Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):537-40. Eur Rev Med Pharmacol Sci. 2013. PMID: 23467955 Free article.

2

Contribution of myo-inositol and melatonin to human reproduction.

Carlomagno G, Nordio M, Chiu TT, Unfer V. Carlomagno G, et al. Among authors: nordio m. Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):267-72. doi: 10.1016/j.ejogrb.2011.07.038. Epub 2011 Aug 10. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21835536 Review.

3

The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.

Nordio M, Proietti E. Nordio M, et al. Eur Rev Med Pharmacol Sci. 2012 May;16(5):575-81. Eur Rev Med Pharmacol Sci. 2012. PMID: 22774396 Clinical Trial.

4

Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis.

Nordio M, Pajalich R. Nordio M, et al. J Thyroid Res. 2013;2013:424163. doi: 10.1155/2013/424163. Epub 2013 Oct 2. J Thyroid Res. 2013. PMID: 24224112 Free PMC article.

5

A novel treatment for subclinical hyperthyroidism: a pilot study on the beneficial effects of l-carnitine and selenium.

Nordio M. Nordio M. Eur Rev Med Pharmacol Sci. 2017 May;21(9):2268-2273. Eur Rev Med Pharmacol Sci. 2017. PMID: 28537653 Free article.

6

Editorial - Modern approach to the infertile male: the use of andrositol® test (myo-inositol in diagnostics).

Nordio M. Nordio M. Eur Rev Med Pharmacol Sci. 2017 Jun;21(2 Suppl):60-61. Eur Rev Med Pharmacol Sci. 2017. PMID: 28724174 Free article. No abstract available.

7

Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism.

Nordio M, Basciani S. Nordio M, et al. Eur Rev Med Pharmacol Sci. 2017 Jun;21(2 Suppl):51-59. Eur Rev Med Pharmacol Sci. 2017. PMID: 28724185 Free article. Clinical Trial.

8

Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment.

Nordio M, Basciani S. Nordio M, et al. Eur Rev Med Pharmacol Sci. 2018 Apr;22(7):2153-2159. doi: 10.26355/eurrev_201804_14749. Eur Rev Med Pharmacol Sci. 2018. PMID: 29687875 Free article.

9

The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.

Nordio M, Basciani S, Camajani E. Nordio M, et al. Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5512-5521. doi: 10.26355/eurrev_201906_18223. Eur Rev Med Pharmacol Sci. 2019. PMID: 31298405 Free article. Clinical Trial.

10

Inositols: From Established Knowledge to Novel Approaches.

Dinicola S, Unfer V, Facchinetti F, Soulage CO, Greene ND, Bizzarri M, Laganà AS, Chan SY, Bevilacqua A, Pkhaladze L, Benvenga S, Stringaro A, Barbaro D, Appetecchia M, Aragona C, Bezerra Espinola MS, Cantelmi T, Cavalli P, Chiu TT, Copp AJ, D'Anna R, Dewailly D, Di Lorenzo C, Diamanti-Kandarakis E, Hernández Marín I, Hod M, Kamenov Z, Kandaraki E, Monastra G, Montanino Oliva M, Nestler JE, Nordio M, Ozay AC, Papalou O, Porcaro G, Prapas N, Roseff S, Vazquez-Levin M, Vucenik I, Wdowiak A. Dinicola S, et al. Among authors: nordio m. Int J Mol Sci. 2021 Sep 30;22(19):10575. doi: 10.3390/ijms221910575. Int J Mol Sci. 2021. PMID: 34638926 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page